Ifp Advisors, Inc Bio Line Rx Ltd. Transaction History

Ifp Advisors, Inc

3 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$2.65 - $3.35 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$2.63 - $4.88 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$2.38 - $4.0 $0 - $0	0 New

3.35M

46.5K

6.3K

Ticker BLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,524,500
Market Cap $12.3M
Description
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.